Cargando…
Modeling cancer driver events in vitro using barrier bypass-clonal expansion assays and massively parallel sequencing
The information on candidate cancer driver alterations available from public databases is often descriptive and of limited mechanistic insight, which poses difficulties for reliable distinction between true driver and passenger events. To address this challenge, we performed in-depth analysis of who...
Autores principales: | Huskova, H, Ardin, M, Weninger, A, Vargova, K, Barrin, S, Villar, S, Olivier, M, Stopka, T, Herceg, Z, Hollstein, M, Zavadil, J, Korenjak, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666318/ https://www.ncbi.nlm.nih.gov/pubmed/28692054 http://dx.doi.org/10.1038/onc.2017.215 |
Ejemplares similares
-
Experimental identification of cancer driver alterations in the era of pan‐cancer genomics
por: Korenjak, Michael, et al.
Publicado: (2019) -
Base changes in tumour DNA have the power to reveal the causes and evolution of cancer
por: Hollstein, M, et al.
Publicado: (2017) -
Corrigendum: Modelling mutational landscapes of human cancers in vitro
por: Olivier, Magali, et al.
Publicado: (2017) -
Modelling mutational landscapes of human cancers in vitro
por: Olivier, Magali, et al.
Publicado: (2014) -
Differential expression, localization and activity of MARCKS between mantle cell lymphoma and chronic lymphocytic leukemia
por: Vargova, J, et al.
Publicado: (2016)